Orphalan announces NMPA™s approval of its trientine tetrahydrochloride product
18 Jan 2024 //
GLOBENEWSWIRE
FDA Confirms Paragraph IV Patent Litigation for Trientine Tetrahydrochloride
08 Aug 2023 //
FDA
PANTHERx® Rare Announces Release of CUVRIOR to Treat Wilson Disease
19 Apr 2023 //
PR NEWSWIRE